Remifentanil versus dexmedetomidine

A comparison of risk of hypotension using standard doses of remifentanil versus dexmedetomidine infusions, in adult patients undergoing elective surgery under general anaesthesia at the Aga Khan University Hospital, Nairobi.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201412000962379

Enrollment

100

Registered

2014-12-06

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Hypotension

Interventions

Dexmedetomidine infusion

Remifentanil infusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I or II patients Patients aged 18-85 years Elective surgical procedures

Exclusion criteria

Exclusion criteria: BMI >35 Pregnant women Patients with severe liver and renal dysfunction Patients diagnosed to have mental disorders Pre-existing bradycardia and brady-dysrhythmia Cardiovascular insufficiency and valvular heart disease Hypertensive patients

Design outcomes

Primary

Measure	Time frame
hypotension	—

Secondary

Measure	Time frame
severity of hypotension;number of physician interventions	—

Countries

Kenya

Contacts

Public ContactCiiru Kamanda

Research Unit Co-ordinator

kamanda.ciiru@aku.edu+254203662107/2109

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026